Develops bacterial-based immunotherapies that colonise solid tumours to stimulate robust CD8⁺ T-cell responses.
Mantis Therapeutics
Details
- LSH Companies
Galileiweg 8, 2333 BD, Leiden
Develops bacterial-based immunotherapies that colonise solid tumours to stimulate robust CD8⁺ T-cell responses.
Galileiweg 8, 2333 BD, Leiden